| answer text |
<p>Personal Independence Payment (PIP) has different eligibility criteria to Disability
Living Allowance (DLA), and takes a more holistic view of a person’s health condition
or disability and the impact it has on their ability to live an independent life.
Therefore, when a DLA claimant is invited to claim PIP and is reassessed, the level
of their award may stay the same, go up, down or cease altogether depending on their
assessed level of need. It is important to note that the claimant may no longer have
the condition recorded in the DLA system when they apply for PIP.</p><p>We introduced
PIP to replace the outdated DLA system. PIP is a fairer benefit, which takes a much
wider look at the way an individual’s health condition or disability impacts them
on a daily basis. Under PIP, 30 per cent of claimants are receiving the highest possible
support, compared with just 15 per cent under DLA.</p><p><strong> </strong></p><p>3,480
DLA claimants with Leukaemia have been reassessed from DLA to PIP and of this 1,080
received a reduced award amount on PIP compared to DLA, 840 were disallowed PIP post
referral to the Assessment Provider and 140 were disallowed PIP pre-referral to the
Assessment Provider.</p><p> </p><p>520 DLA claimants with Myeloma have been reassessed
from DLA to PIP and of this 200 received a reduced award amount on PIP compared to
DLA, 70 were disallowed PIP post referral to the Assessment Provider and 10 were disallowed
PIP pre-referral to the Assessment Provider.</p><p> </p><p>300 DLA claimants with
Hodgkin's lymphoma have been reassessed from DLA to PIP and of this 100 received a
reduced award amount on PIP compared to DLA, 90 were disallowed PIP post referral
to the Assessment Provider and 20 were disallowed PIP pre-referral to the Assessment
Provider.</p><p> </p><p>660 DLA claimants with non-Hodgkin's lymphoma have been reassessed
from DLA to PIP and of this 240 received a reduced award amount on PIP compared to
DLA, 160 were disallowed PIP post referral to the Assessment Provider and 20 were
disallowed PIP pre-referral to the Assessment Provider.</p><p> </p><p><strong>Notes</strong></p><ul><li>The
category “Leukaemia” includes 6 categories under the DLA computer system - Leukaemia
- myelogenous (myeloid) acute, Leukaemia - lymphoblastic – acute, Leukaemia - myeloid
- chronic, Leukaemia - lymphocytic – chronic, Leukaemias - Other / type not known,
Cancer and Leukaemia.</li><li>The PIP Reassessment outcome is the outcome of the first
DWP decision on each reassessment claim (i.e. prior to any reconsideration, appeal
action and award review), where that decision was made between 1st October 2013 and
31st October 2017.</li><li>Claimants that withdrew their claim to PIP are excluded.</li><li>DLA
Entitlement is the DLA award at the time of PIP reassessment registration.</li><li>Reassessment
outcomes are for individuals who were aged 16 to 64 on 8th April 2013.</li><li>Data
includes PIP claims made under both Normal Rules and Special Rules for the Terminally
Ill. However, under DLA a claimant can be recorded as “Terminally Ill” rather than
as having a named disability. Therefore, such cases are excluded from the above figures.</li><li>The
statistics provided relate to DLA award levels so primary disabling condition is reported
as recorded on the DLA computer system. Claimants may often have multiple disabling
conditions upon which the decision is based but only the primary condition is shown
in these statistics.</li><li>Primary disabling condition may be recorded differently
on the PIP and DLA computer systems.</li><li>Figures are rounded to the nearest 10.</li><li>Great
Britain only.</li></ul>
|
|
